Explore findings from the 2026 Cell and Gene Therapy Report on oncology adoption, emerging specialties, reimbursement and ...

NEW YORK, IRVING, Texas and BANNOCKBURN, Ill., October 6, 2026 — CD&R, McKesson Corporation (NYSE: MCK) (“McKesson”), and Option Care Health, Inc. (Nasdaq: OPCH) (“Option Care Health”) announced today ...

InspiroGene™ by McKesson research across providers, payers, patients and advocates highlights persistent access barriers and explores how technology and AI could help close the gap Average number of ...

IRVING, Texas, October 1, 2026—McKesson Corporation (NYSE: MCK) announced today that it has signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to ...

See how two Health Mart pharmacies connect patients to medications, services and personalized support while helping keep care ...

McKesson is investigating a cybersecurity incident involving third-party applications and unauthorized access and exfiltration of data. McKesson supplies medical equipment, pharmaceuticals, and health ...

IRVING, Texas, August 25, 2026—McKesson Corporation (NYSE: MCK) announced today that it signed a definitive agreement to acquire Precision Medicine Group, LLC (“Precision Medicine Group”), a global ...

IRVING, Texas, August 5, 2026 - McKesson Corporation (NYSE:MCK) today announced results for the first quarter ended June 30, 2026. Consolidated revenues of $105.4 billion increased 8%. Earnings per ...

Distributing one-third of medicines with more than 99% inventory and order accuracy, strengthening advanced cancer care for patients through support of approximately 3,300 independent oncology ...

IRVING, Texas, June 24, 2026 -- McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2027 financial results after market close on Wednesday, August 5, 2026. The company will host a ...

IRVING, Texas, June 2, 2026 – McKesson Corporation (NYSE: MCK) announced today the successful completion of the previously announced minority ownership interest investment from funds managed by ...

IRVING, Texas, May 7, 2026 - McKesson Corporation (NYSE:MCK) today announced results for the fourth quarter and fiscal year ended March 31, 2026. Consolidated revenues of $96.3 billion increased 6%.